Literature DB >> 25316111

Race and ethnicity influences collection of granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells from unrelated donors, a Center for International Blood and Marrow Transplant Research analysis.

Jack W Hsu1, John R Wingard2, Brent R Logan3, Pintip Chitphakdithai4, Gorgun Akpek5, Paolo Anderlini6, Andrew S Artz7, Chris Bredeson8, Steven Goldstein9, Gregory Hale10, Peiman Hematti11, Sarita Joshi12, Rammurti T Kamble13, Hillard M Lazarus14, Paul V O'Donnell15, Michael A Pulsipher16, Bipin N Savani17, Raquel M Schears18, Bronwen E Shaw19, Dennis L Confer20.   

Abstract

Little information exists on the effect of race and ethnicity on collection of peripheral blood stem cells (PBSC) for allogeneic transplantation. We studied 10,776 donors from the National Marrow Donor Program who underwent PBSC collection from 2006 to 2012. Self-reported donor race/ethnic information included Caucasian, Hispanic, Black/African American (AA), Asian/Pacific Islander (API), and Native American (NA). All donors were mobilized with subcutaneous filgrastim at an approximate dose of 10 μg/kg/day for 5 days. Overall, AA donors had the highest median yields of mononuclear cells per liter and CD34(+) cells per liter of blood processed (3.1 × 10(9) and 44 × 10(6), respectively), whereas Caucasians had the lowest median yields at 2.8 × 10(9) and 33.7 × 10(6), respectively. Multivariate analysis of CD34(+) per liter mobilization yields using Caucasians as the comparator and controlling for age, gender, body mass index, and year of apheresis revealed increased yields in overweight and obese AA and API donors. In Hispanic donors, only male obese donors had higher CD34(+) per liter mobilization yields compared with Caucasian donors. No differences in CD34(+) per liter yields were seen between Caucasian and NA donors. Characterization of these differences may allow optimization of mobilization regimens to allow enhancement of mobilization yields without compromising donor safety.
Copyright © 2015 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ethnicity; Granulocyte colony–stimulating factor (G-CSF); Mobilization; Race

Mesh:

Substances:

Year:  2014        PMID: 25316111      PMCID: PMC4272878          DOI: 10.1016/j.bbmt.2014.10.007

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  32 in total

1.  Therapeutic targeting of a stem cell niche.

Authors:  Gregor B Adams; Roderick P Martin; Ian R Alley; Karissa T Chabner; Kenneth S Cohen; Laura M Calvi; Henry M Kronenberg; David T Scadden
Journal:  Nat Biotechnol       Date:  2007-01-21       Impact factor: 54.908

2.  Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow.

Authors:  Yoshio Katayama; Michela Battista; Wei-Ming Kao; Andrés Hidalgo; Anna J Peired; Steven A Thomas; Paul S Frenette
Journal:  Cell       Date:  2006-01-27       Impact factor: 41.582

3.  Stem cell mobilization in normal donors for allogeneic transplantation: analysis of safety and factors affecting efficacy.

Authors:  G Miflin; C Charley; C Stainer; S Anderson; A Hunter; N Russell
Journal:  Br J Haematol       Date:  1996-11       Impact factor: 6.998

4.  Peripheral blood stem cell yield in 400 normal donors mobilised with granulocyte colony-stimulating factor (G-CSF): impact of age, sex, donor weight and type of G-CSF used.

Authors:  Stuart J Ings; Carmen Balsa; David Leverett; Stephen Mackinnon; David C Linch; Michael J Watts
Journal:  Br J Haematol       Date:  2006-09       Impact factor: 6.998

5.  Genetic influences determining progenitor cell mobilization and leukocytosis induced by granulocyte colony-stimulating factor.

Authors:  A W Roberts; S Foote; W S Alexander; C Scott; L Robb; D Metcalf
Journal:  Blood       Date:  1997-04-15       Impact factor: 22.113

6.  Factors affecting mobilization of CD34+ cells in normal donors treated with filgrastim.

Authors:  P Anderlini; D Przepiorka; C Seong; T L Smith; Y O Huh; J Lauppe; R Champlin; M Körbling
Journal:  Transfusion       Date:  1997-05       Impact factor: 3.157

7.  Optimizing dose and scheduling of filgrastim (granulocyte colony-stimulating factor) for mobilization and collection of peripheral blood progenitor cells in normal volunteers.

Authors:  A P Grigg; A W Roberts; H Raunow; S Houghton; J E Layton; A W Boyd; K M McGrath; D Maher
Journal:  Blood       Date:  1995-12-15       Impact factor: 22.113

Review 8.  PBSC mobilization.

Authors:  Kunihiko Takeyama; Hitoshi Ohto
Journal:  Transfus Apher Sci       Date:  2004-12       Impact factor: 1.764

9.  Evidence for alteration of the vitamin D-endocrine system in blacks.

Authors:  N H Bell; A Greene; S Epstein; M J Oexmann; S Shaw; J Shary
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

10.  Haemopoietic stem cell subpopulations in mouse and man: discrimination by differential adherence and marrow repopulating ability.

Authors:  M Y Gordon; A D Bearpark; D Clarke; C R Dowding
Journal:  Bone Marrow Transplant       Date:  1990-01       Impact factor: 5.483

View more
  10 in total

1.  Racial disparities in treatment use for multiple myeloma.

Authors:  Mark A Fiala; Tanya M Wildes
Journal:  Cancer       Date:  2017-01-13       Impact factor: 6.860

2.  Hematopoietic progenitor cell mobilization is more robust in healthy African American compared to Caucasian donors and is not affected by the presence of sickle cell trait.

Authors:  Sandhya R Panch; Yu Ying Yau; Courtney D Fitzhugh; Matthew M Hsieh; John F Tisdale; Susan F Leitman
Journal:  Transfusion       Date:  2016-05       Impact factor: 3.157

3.  Donor Experiences of Second Marrow or Peripheral Blood Stem Cell Collection Mirror the First, but CD34+ Yields Are Less.

Authors:  David F Stroncek; Bronwen E Shaw; Brent R Logan; Deidre M Kiefer; Bipin N Savani; Paolo Anderlini; Christopher N Bredeson; Peiman Hematti; Siddhartha Ganguly; Miguel Angel Diaz; Hisham Abdel-Azim; Ibrahim Ahmed; Dipnarine Maharaj; Matthew Seftel; Amer Beitinjaneh; Sachiko Seo; Jean A Yared; Joerg Halter; Paul V O'Donnell; Gregory A Hale; Zachariah DeFilipp; Hillard Lazarus; Jane L Liesveld; Zheng Zhou; Pashna Munshi; Richard F Olsson; Kimberly Anne Kasow; Jeffrey Szer; Galen E Switzer; Pintip Chitphakdithai; Nirali Shah; Dennis L Confer; Michael A Pulsipher
Journal:  Biol Blood Marrow Transplant       Date:  2017-09-25       Impact factor: 5.742

4.  The Impact of Pre-Apheresis Health Related Quality of Life on Peripheral Blood Progenitor Cell Yield and Donor's Health and Outcome: Secondary Analysis of Patient-Reported Outcome Data from the RDSafe and BMT CTN 0201 Clinical Trials.

Authors:  Nosha Farhadfar; Kwang Woo Ahn; Stephanie Bo-Subait; Brent Logan; Heather E Stefanski; Jack W Hsu; Sandhya Panch; Dennis Confer; Hien Liu; Sherif M Badawy; Amer Beitinjaneh; Miguel A Diaz; Gerhard C Hildebrandt; Amar H Kelkar; Hillard M Lazarus; Hemant S Murthy; Jaime M Preussler; Raquel M Schears; Akshay Sharma; Marjolein van der Poel; Jessica G Bruce; Michael A Pulsipher; Bronwen E Shaw; John R Wingard; Galen E Switzer
Journal:  Transplant Cell Ther       Date:  2022-06-07

5.  Circulating Progenitor Cells and Racial Differences.

Authors:  Ayman Samman Tahhan; Muhammad Hammadah; Heval Mohamed Kelli; Jeong Hwan Kim; Pratik B Sandesara; Ayman Alkhoder; Belal Kaseer; Mohamad Mazen Gafeer; Matthew Topel; Salim S Hayek; Wesley T O'Neal; Malik Obideen; Yi-An Ko; Chang Liu; Iraj Hesaroieh; Ernestine Mahar; Viola Vaccarino; Edmund K Waller; Arshed A Quyyumi
Journal:  Circ Res       Date:  2018-08-03       Impact factor: 17.367

6.  Method comparison study of peripheral blood CD34+ count performed on an Abbott CELL-DYN Sapphire hematology analyzer versus flow cytometry reference procedure (modified ISHAGE).

Authors:  Scott T Avecilla; Cheryl Goss; Steven M Marionneaux; Donald R Wright; Tyler D Leiva; Jo-Ann Tonon; Katherine M Smith; Peter Maslak
Journal:  Adv Cell Gene Ther       Date:  2018-08-13

7.  Chorioamnionitis Induces a Specific Signature of Placental ABC Transporters Associated with an Increase of miR-331-5p in the Human Preterm Placenta.

Authors:  Guinever Eustaquio do Imperio; Enrrico Bloise; Mohsen Javam; Phetcharawan Lye; Andrea Constantinof; Caroline Dunk; Fernando Marcos Dos Reis; Stephen James Lye; William Gibb; Tania M Ortiga-Carvalho; Stephen Giles Matthews
Journal:  Cell Physiol Biochem       Date:  2018-01-29

Review 8.  Putting the Pieces Together: Completing the Mechanism of Action Jigsaw for Sipuleucel-T.

Authors:  Ravi A Madan; Emmanuel S Antonarakis; Charles G Drake; Lawrence Fong; Evan Y Yu; Douglas G McNeel; Daniel W Lin; Nancy N Chang; Nadeem A Sheikh; James L Gulley
Journal:  J Natl Cancer Inst       Date:  2020-06-01       Impact factor: 13.506

9.  Weighty choices: selecting optimal G-CSF doses for stem cell mobilization to optimize yield.

Authors:  Nosha Farhadfar; Jack W Hsu; Brent R Logan; Jennifer A Sees; Pintip Chitphakdithai; Michele W Sugrue; Hisham Abdel-Azim; Paolo N Anderlini; Christopher Bredeson; Saurabh Chhabra; Miguel Angel Diaz; Siddhartha Ganguly; Peiman Hematti; Rammurti T Kamble; Kimberly A Kasow; Hillard M Lazarus; Debra Kelly Lynch; Hemant S Murthy; Richard F Olsson; Mona Papari; Donna Przepiorka; Bipin N Savani; Raquel Schears; Sachiko Seo; Melhem M Solh; Thomas Spitzer; Jean A Yared; Michael A Pulsipher; Nirali N Shah; Galen E Switzer; Dennis L Confer; Bronwen E Shaw; John R Wingard
Journal:  Blood Adv       Date:  2020-02-25

10.  Analysis of Circulating Immune Biomarkers by Race in Men With Metastatic Castration-Resistant Prostate Cancer Treated With Sipuleucel-T.

Authors:  Jessica E Hawley; Samuel Pan; Harini Kandadi; Matthew G Chaimowitz; Nadeem Sheikh; Charles G Drake
Journal:  J Natl Cancer Inst       Date:  2022-02-07       Impact factor: 13.506

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.